Clinical Trial Update: RIVOS Feasibility (MBO) [NA]

View source ↗

Summary

The RIVOS feasibility trial for malignant biliary obstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Biliary Obstruction

Drugs mentioned

• RIVOS

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Malignant Biliary Obstruction | NA | Status: WITHDRAWN